Dratwa M - Search Results

1

Performance of an immunoradiometric assay of erythropoietin and results for specimens from anemic and polycythemic patients.

Andre M, Ferster A, Toppet M, Fondu P, Dratwa M, Bergmann P. Andre M, et al. Among authors: dratwa m. Clin Chem. 1992 May;38(5):758-63. Clin Chem. 1992. PMID: 1582031

2

Responsiveness to recombinant erythropoietin therapy in end-stage renal disease. An analysis of the predictive value of several biological measurements, including circulating erythroid progenitors.

Corazza F, Bergmann P, Dratwa M, Guns M, Fondu P. Corazza F, et al. Among authors: dratwa m. Nephrol Dial Transplant. 1992;7(4):311-7. doi: 10.1093/oxfordjournals.ndt.a092134. Nephrol Dial Transplant. 1992. PMID: 1317521

3

Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease.

Mesquita M, Demulder A, Damry N, Mélot C, Wittersheim E, Willems D, Dratwa M, Bergmann P. Mesquita M, et al. Among authors: dratwa m. Clin Chem Lab Med. 2009;47(3):339-46. doi: 10.1515/CCLM.2009.075. Clin Chem Lab Med. 2009. PMID: 19676147

4

Quantitative ultrasound and dual X-ray absorptiometry measurements of the calcaneus in patients on maintenance hemodialysis.

Peretz A, Penaloza A, Mesquita M, Dratwa M, Verhas M, Martin P, de Maertelaer V, Bergmann P. Peretz A, et al. Among authors: dratwa m. Bone. 2000 Aug;27(2):287-92. doi: 10.1016/s8756-3282(00)00320-3. Bone. 2000. PMID: 10913924 Clinical Trial.

5

Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?

Tielemans C, Dratwa M, Bergmann P, Goldman M, Flamion B, Collart F, Wens R. Tielemans C, et al. Among authors: dratwa m. Nephrol Dial Transplant. 1988;3(3):291-4. Nephrol Dial Transplant. 1988. PMID: 3140103

6

OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis.

Wittersheim E, Mesquita M, Demulder A, Guns M, Louis O, Melot C, Dratwa M, Bergmann P. Wittersheim E, et al. Among authors: dratwa m. Clin Biochem. 2006 Jun;39(6):617-22. doi: 10.1016/j.clinbiochem.2006.01.020. Epub 2006 Mar 10. Clin Biochem. 2006. PMID: 16530745

7

Bone cytokines and renal osteodystrophy in peritoneal dialysis patients.

Mesquita M, Wittersheim E, Demulder A, Dratwa M, Bergmann P. Mesquita M, et al. Among authors: dratwa m. Adv Perit Dial. 2005;21:181-4. Adv Perit Dial. 2005. PMID: 16686314

8

Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease.

Mesquita M, Demulder A, Wolff F, Mélot C, Damry N, Dratwa M, Bergmann P. Mesquita M, et al. Among authors: dratwa m. Transplant Proc. 2010 Nov;42(9):3444-9. doi: 10.1016/j.transproceed.2010.09.129. Transplant Proc. 2010. PMID: 21094794

9

Hemodynamics of patients with renal failure treated with recombinant human erythropoietin.

Verbeelen D, Bossuyt A, Smitz J, Herman A, Dratwa M, Jonckheer MH. Verbeelen D, et al. Among authors: dratwa m. Clin Nephrol. 1989 Jan;31(1):6-11. Clin Nephrol. 1989. PMID: 2914412

10

Effects of recombinant human erythropoietin on T lymphocyte subsets in hemodialysis patients.

Collart FE, Dratwa M, Wittek M, Wens R. Collart FE, et al. Among authors: dratwa m. ASAIO Trans. 1990 Jul-Sep;36(3):M219-23. ASAIO Trans. 1990. PMID: 2147556 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters